Understanding how chemotherapy affects mobility and falls in cancer patients
Patterns and predictors of symptoms, falls, and functioning across treatment and recovery in patients treated with neurotoxic chemotherapy for cancer
['FUNDING_R01'] · OREGON HEALTH & SCIENCE UNIVERSITY · NIH-10907687
This study is looking at how chemotherapy affects cancer patients' ability to move around and their chances of falling, so we can better understand which patients might need extra help during treatment.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | OREGON HEALTH & SCIENCE UNIVERSITY (nih funded) |
| Locations | 1 site (PORTLAND, UNITED STATES) |
| Trial ID | NIH-10907687 on ClinicalTrials.gov |
What this research studies
This research investigates the impact of neurotoxic chemotherapy on cancer patients, particularly focusing on how it affects their mobility and increases the risk of falls. By tracking symptoms, mobility, and falls before, during, and after treatment, the study aims to identify which patients are most at risk and what specific mobility issues contribute to falls. The approach includes detailed symptom tracking, clinical tests, and continuous monitoring of daily activities. The goal is to provide insights that can help clinicians and rehabilitation providers improve care for patients undergoing chemotherapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients who are being treated with neurotoxic chemotherapy.
Not a fit: Patients who are not undergoing neurotoxic chemotherapy or those with conditions unrelated to cancer treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better prevention strategies for falls and functional decline in cancer patients undergoing chemotherapy.
How similar studies have performed: Other research has indicated that understanding mobility issues in cancer patients can lead to improved outcomes, suggesting that this approach has potential for success.
Where this research is happening
PORTLAND, UNITED STATES
- OREGON HEALTH & SCIENCE UNIVERSITY — PORTLAND, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WINTERS-STONE, KERRI M — OREGON HEALTH & SCIENCE UNIVERSITY
- Study coordinator: WINTERS-STONE, KERRI M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.